Russell Investments Group’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.9K Sell
33,148
-105
-0.3% -$57 ﹤0.01% 3222
2025
Q1
$21.8K Buy
33,253
+6,939
+26% +$4.55K ﹤0.01% 3093
2024
Q4
$26.8K Sell
26,314
-14,492
-36% -$14.8K ﹤0.01% 2955
2024
Q3
$35.3K Buy
40,806
+18,229
+81% +$15.8K ﹤0.01% 2848
2024
Q2
$8.09K Buy
22,577
+16,299
+260% +$5.84K ﹤0.01% 3125
2024
Q1
$4.21K Sell
6,278
-94,744
-94% -$63.5K ﹤0.01% 2966
2023
Q4
$54.9K Sell
101,022
-1,279
-1% -$695 ﹤0.01% 2629
2023
Q3
$61.4K Sell
102,301
-2,387
-2% -$1.43K ﹤0.01% 2718
2023
Q2
$136K Sell
104,688
-91,218
-47% -$119K ﹤0.01% 2548
2023
Q1
$345K Buy
195,906
+94,545
+93% +$166K ﹤0.01% 2366
2022
Q4
$318K Hold
101,361
﹤0.01% 2444
2022
Q3
$496K Buy
101,361
+67,961
+203% +$333K ﹤0.01% 2248
2022
Q2
$138K Buy
+33,400
New +$138K ﹤0.01% 2612
2021
Q2
Sell
-77,714
Closed -$964K 3287
2021
Q1
$964K Sell
77,714
-32,369
-29% -$402K ﹤0.01% 2261
2020
Q4
$1.72M Sell
110,083
-6,788
-6% -$106K ﹤0.01% 1838
2020
Q3
$1.1M Buy
116,871
+8,500
+8% +$80.3K ﹤0.01% 2023
2020
Q2
$971K Buy
108,371
+51,091
+89% +$458K ﹤0.01% 2073
2020
Q1
$364K Sell
57,280
-44,012
-43% -$280K ﹤0.01% 2316
2019
Q4
$846K Hold
101,292
﹤0.01% 2187
2019
Q3
$917K Buy
101,292
+1,833
+2% +$16.6K ﹤0.01% 2046
2019
Q2
$1.07M Hold
99,459
﹤0.01% 1955
2019
Q1
$948K Hold
99,459
﹤0.01% 2092
2018
Q4
$1.14M Sell
99,459
-6,435
-6% -$73.7K ﹤0.01% 1880
2018
Q3
$1.8M Buy
105,894
+69,984
+195% +$1.19M ﹤0.01% 1812
2018
Q2
$509K Hold
35,910
﹤0.01% 2386
2018
Q1
$682K Sell
35,910
-3,045
-8% -$57.8K ﹤0.01% 2362
2017
Q4
$665K Sell
38,955
-31,719
-45% -$541K ﹤0.01% 2333
2017
Q3
$1.06M Buy
70,674
+47,579
+206% +$714K ﹤0.01% 2113
2017
Q2
$203K Buy
+23,095
New +$203K ﹤0.01% 2688
2017
Q1
Sell
-58,739
Closed -$179K 3065
2016
Q4
$179K Buy
+58,739
New +$179K ﹤0.01% 2735